CoChat

Plasma Steroid Profiles in Subclinical Compared With Overt Adrenal Cushing Syndrome

Open access
Masjkur, Jimmy, Gruber, Matthias, Peitzsch, Mirko, Kaden, Denise, Di Dalmazi, Guido, Bidlingmaier, Martin, Zopp, Stephanie, Langton, Katharina, Fazel, Julia, Beuschlein, Felix, Bornstein, Stefan Richard, Reincke, Martin, Eisenhofer, Graeme · 2019 · The Journal of Clinical Endocrinology & Metabolism
Cited by 51

The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.

Abstract

Context: Diagnosis of subclinical adrenal hypercortisolism is based on several tests of the hypothalamic-pituitary-adrenal axis to establish mild alterations of cortisol secretion and dysregulated cortisol physiology. Objective: We assessed whether plasma steroid profiles might assist diagnosis of subclinical Cushing syndrome (SC). Design: Retrospective cross-sectional study. Setting: Two tertiary medical centers. Patients: Of 208 patients tested for hypercortisolism, disease was excluded in 152 and confirmed in 21 with overt adrenal Cushing syndrome (AC) compared to 35 with SC. Another 277 age- and sex-matched hypertensive and normotensive volunteers were included for reference. Main Outcome Measures: A panel of 15 plasma steroids was measured by mass spectrometry, with classification by discriminant analysis. Results: Patients with SC had lower plasma concentrations of dehydroepiandrosterone and dehydroepiandrosterone-sulfate than subjects without SC (P < 0.05). The largest increases (P < 0.001) in plasma steroids among patients with SC were observed for 11-deoxycortisol and 11-deoxycorticosterone. Nevertheless, concentrations of 11-deoxycorticosterone, 11-deoxycortisol, and pregnenolone in patients with AC were higher (P < 0.05) than in those with SC. Patients with SC or AC could be distinguished from subjects without disease using this combination of steroids as precisely as with use of measurements of serum cortisol after administration of dexamethasone. The steroid combination provided superior diagnostic performance compared with each of the other routine biochemical tests. Conclusion: Distinct plasma steroid profiles in patients with SC may provide a simple and reliable screening method for establishing the diagnosis.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1210/jc.2018-02349

Cites

12 of 12 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 12 references

Research works printed but not linked: 28

  1. Debono, 2015, Subclinical hypercortisolism in adrenal incidentaloma, Curr Opin Endocrinol Diabetes Obes, 22, 185, 10.1097/MED.0000000000000151 · DOI · Paper page
  2. Di Dalmazi, 2015, Subclinical hypercortisolism: a state, a syndrome, or a disease, Eur J Endocrinol, 173, M61, 10.1530/EJE-15-0272 · DOI · Paper page
  3. Nieman, 2015, Update on subclinical Cushing’s syndrome, Curr Opin Endocrinol Diabetes Obes, 22, 180, 10.1097/MED.0000000000000159 · DOI · Paper page
  4. Akaza, 2011, Clinical outcome of subclinical Cushing’s syndrome after surgical and conservative treatment, Hypertens Res, 34, 1111, 10.1038/hr.2011.90 · DOI
  5. Di Dalmazi, 2015, Adrenal adenomas, subclinical hypercortisolism, and cardiovascular outcomes, Curr Opin Endocrinol Diabetes Obes, 22, 163, 10.1097/MED.0000000000000153 · DOI
  6. Doi, 2008, Late-night salivary cortisol as a screening test for the diagnosis of Cushing’s syndrome in Japan, Endocr J, 55, 121, 10.1507/endocrj.K07E-023 · DOI · Paper page
  7. Gagliardi, 2010, Subclinical Cushing’s syndrome in adrenal incidentaloma: a common problem or an artefact of current diagnostic testing, Clin Endocrinol (Oxf), 72, 277, 10.1111/j.1365-2265.2009.03616.x · DOI
  8. Eisenhofer, 2018, Plasma steroid metabolome profiling for diagnosis and subtyping patients with Cushing syndrome, Clin Chem, 64, 586, 10.1373/clinchem.2017.282582 · DOI · Paper page
  9. Kotłowska, 2017, Metabolomic biomarkers in urine of Cushing’s syndrome patients, Int J Mol Sci, 18, E294, 10.3390/ijms18020294 · DOI · Paper page
  10. Kikuchi, 2000, Urinary steroid profile in adrenocortical tumors, Biomed Pharmacother, 54, 194s, 10.1016/S0753-3322(00)80043-8 · DOI
  11. Shackleton, 2010, Clinical steroid mass spectrometry: a 45-year history culminating in HPLC-MS/MS becoming an essential tool for patient diagnosis, J Steroid Biochem Mol Biol, 121, 481, 10.1016/j.jsbmb.2010.02.017 · DOI · Paper page
  12. Wooding, 2013, Mass spectrometry theory and application to adrenal diseases, Mol Cell Endocrinol, 371, 201, 10.1016/j.mce.2012.12.026 · DOI · Paper page
  13. Wilkes, 2018, Using machine learning to aid the interpretation of urine steroid profiles, Clin Chem, 64, 1586, 10.1373/clinchem.2018.292201 · DOI · Paper page
  14. Eisenhofer, 2017, Reference intervals for plasma concentrations of adrenal steroids measured by LC-MS/MS: Impact of gender, age, oral contraceptives, body mass index and blood pressure status, Clin Chim Acta, 470, 115, 10.1016/j.cca.2017.05.002 · DOI · Paper page
  15. Meyer, 2018, Immunohistopathology and steroid profiles associated with biochemical outcomes after adrenalectomy for unilateral primary aldosteronism, Hypertension, 72, 650, 10.1161/HYPERTENSIONAHA.118.11465 · DOI
  16. Eisenhofer, 2016, Mass spectrometry-based adrenal and peripheral venous steroid profiling for subtyping primary aldosteronism, Clin Chem, 62, 514, 10.1373/clinchem.2015.251199 · DOI · Paper page
  17. Williams, 2016, Genotype-specific steroid profiles associated with aldosterone-producing adenomas, Hypertension, 67, 139, 10.1161/HYPERTENSIONAHA.115.06186 · DOI · Paper page
  18. Stewart, 2010, Is subclinical Cushing’s syndrome an entity or a statistical fallout from diagnostic testing? Consensus surrounding the diagnosis is required before optimal treatment can be defined, J Clin Endocrinol Metab, 95, 2618, 10.1210/jc.2010-0633 · DOI · Paper page
  19. Di Dalmazi, 2014, Cardiovascular events and mortality in patients with adrenal incidentalomas that are either non-secreting or associated with intermediate phenotype or subclinical Cushing’s syndrome: a 15-year retrospective study, Lancet Diabetes Endocrinol, 2, 396, 10.1016/S2213-8587(13)70211-0 · DOI · Paper page
  20. Boizel, 1986, Pattern of plasma levels of cortisol, dehydroepiandrosterone and pregnenolone sulphate in normal subjects and in patients with homozygous familial hypercholesterolaemia during ACTH infusion, Clin Endocrinol (Oxf), 25, 363, 10.1111/j.1365-2265.1986.tb01702.x · DOI
  21. El Asmar, 2018, The value of perioperative levels of ACTH, DHEA, and DHEA-S and tumor size in predicting recurrence of Cushing disease, J Clin Endocrinol Metab, 103, 477, 10.1210/jc.2017-01797 · DOI
  22. Francucci, 2008, Adrenal incidentaloma: effects on bone metabolism, J Endocrinol Invest, 31, 48
  23. Yener, 2015, DHEAS for the prediction of subclinical Cushing’s syndrome: perplexing or advantageous, Endocrine, 48, 669, 10.1007/s12020-014-0387-7 · DOI
  24. Morio, 1996, Serum levels of dehydroepiandrosterone sulfate in patients with asymptomatic cortisol producing adrenal adenoma: comparison with adrenal Cushing’s syndrome and non-functional adrenal tumor, Endocr J, 43, 387, 10.1507/endocrj.43.387 · DOI
  25. Yamaji, 1984, Serum dehydroepiandrosterone sulfate in Cushing’s syndrome, J Clin Endocrinol Metab, 59, 1164, 10.1210/jcem-59-6-1164 · DOI · Paper page
  26. Lee, 2008, A case of Cushing’s syndrome presenting as endometrial hyperplasia, Korean J Intern Med (Korean Assoc Intern Med), 23, 49
  27. McKenna, 1977, Plasma pregnenolone and 17-OH-pregnenolone in patients with adrenal tumors, ACTH excess, or idiopathic hirsutism, J Clin Endocrinol Metab, 44, 231, 10.1210/jcem-44-2-231 · DOI
  28. Haan, 2017, Patient-specific workup of adrenal incidentalomas, Eur J Radiol Open, 4, 108, 10.1016/j.ejro.2017.08.002 · DOI

Cited by

See all 51

Metadata

Authors
Masjkur, J., Gruber, M., Peitzsch, M., Kaden, D., Di Dalmazi, G., Bidlingmaier, M., Zopp, S., Langton, K., Fazel, J., Beuschlein, F., Bornstein, S. R., Reincke, M., & Eisenhofer, G.
Venue
The Journal of Clinical Endocrinology & Metabolism
Published
2019-04-12
Volume
104
Issue
10
Pages
4331-4340
ISSN
  • 0021-972X (ISSN-L)
  • 1945-7197
OpenAlex
W2937853280
Cited by
51
References
12
FWCI
4.99
Type
journal article
Language
en
Open access
hybrid
Funders
  • Else Kröner-Fresenius-Stiftung (2015_A228, 2012_A103)
  • H2020 European Research Council (694913)
  • Deutsche Forschungsgemeinschaft (CRC/TRR 205)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Plasma Steroid Profiles in Subclinical Compared With Overt Adrenal Cushing Syndrome. https://app.cochat.ai/papers/10.1210/jc.2018-02349
The paper
Masjkur, J., Gruber, M., Peitzsch, M., Kaden, D., Di Dalmazi, G., Bidlingmaier, M., Zopp, S., Langton, K., Fazel, J., Beuschlein, F., Bornstein, S. R., Reincke, M., & Eisenhofer, G. (2019). Plasma Steroid Profiles in Subclinical Compared With Overt Adrenal Cushing Syndrome. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/jc.2018-02349

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.